Overview of Blood Transfusion System of Iran: 2002–2011

Despite importance of blood transfusion services as life saving procedures, some countries are unable to meet their national requirements for blood and blood components in a timely manner. Since establishment of Iran Blood Transfusion Organization (IBTO) in 1974 as an integral part of national health system, Iran has experienced a drastic improvement both in availability and safety of blood and blood products. Iran now has not only reached to a 100% non remunerated voluntary blood donation but also secured a national self sufficiency of blood and blood components. Efforts of IBTO as the sole player of transfusion medicines in Iran enabled the country for timely providing of life saving blood transfusion services for all Iranian patients in need of such services. In order to meet the country’s demand in 2011 about 2 million units of whole blood for a population of about 75 million collected by IBTO. This indicates 26.2 donations per 1000 population. Currently about 94% of blood donors in Iran are 25–35 years old males and contribution of female donors in blood donation is less than 6%. IBTO screen all donated blood for important transfusion transmissible infections such as HBV, HIV, HCV and syphilis. Prevalence of HBsAg, HCV and HIV in donated blood in IBTO in 2011 was 0.20%, 0.06% and 0.004% respectively.

[1]  E. B. Shirling,et al.  Methods for characterization of Streptomyces species , 1966 .

[2]  R. Shinobu,et al.  On Streptomyces indigoferus nov. sp., Producing Blue to Green Soluble Pigment on Some Synthetic Media , 1961 .

[3]  G. Toogeh,et al.  Short‐term ferrous sulfate supplementation in female blood donors , 2008, Transfusion.

[4]  A. Cheraghali.  Blood safety concerns in the Eastern Mediterranean region , 2011, Hepatitis monthly.

[5]  R. Shinobu,et al.  On Streptomyces herbaricolor nov. sp. : Supplement A simple technique for the microscopical observation , 1960 .

[6]  H. B. Woodruff,et al.  Discovery and antimicrobial properties of cathomycin, a new antibiotic produced by Streptomyces spheroides n. sp. , 1955, Antibiotics annual.

[7]  S. Waksman.  CULTURAL STUDIES OF SPECIES OF ACTINOMYCES , 1919 .

[8]  A. Matsumae,et al.  Melanomycin, a new antitumor substance from Streptomyces. I. , 1957, The Journal of antibiotics.

[9]  E. B. Shirling,et al.  Cooperative description of type cultures of Streptomyces.: II. Species descriptions from first study , 1968 .

[10]  Alavian SeyedMoayed,et al.  Hepatitis B Virus Infection in Iran: A Systematic Review , 2008 .

[11]  M. F. Mobley,et al.  Recruitment and retention of blood donors: A strategic linkage approach , 1993, Health care management review.

[12]  H. Abolghasemi,et al.  Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience , 2009, Haemophilia.

[13]  Herbert E. Carter,et al.  Endomycin, a new antibiotic. , 1951 .

[14]  J. Berger,et al.  Borrelidin, a new antibiotic with antiborrelia activity and penicillin enhancement properties. , 1949, Archives of biochemistry.

[15]  M. Radfar,et al.  Thalassemia in Iran: Epidemiology, Prevention, and Management , 2007, Journal of pediatric hematology/oncology.

[16]  S. A. Kafi-Abad,et al.  INTRODUCTION TO IRANIAN BLOOD TRANSFUSION ORGANIZATION AND BLOOD SAFETY IN IRAN , 2009 .

[17]  H. D. Tresner,et al.  ELECTRON MICROSCOPY OF STREPTOMYCES SPORE MORPHOLOGY AND ITS ROLE IN SPECIES DIFFERENTIATION , 1961, Journal of bacteriology.

[18]  D. Gottlieb,et al.  Plant disease control with antibiotics , 1952, Economic Botany.

[19]  D. Erikson.  Medical Research Council. The Pathogenic Aerobic Organisms of the Actinomyces Group , 1936, The Indian Medical Gazette.

[20]  K. Au,et al.  A new antibiotic? , 1969, Biochemical pharmacology.

[21]  Herbert E. Carter,et al.  Filipin, an antibiotic effective against fungi. , 1955 .